Firearm-related injuries drop during NRA conventions

(Reuters Health) - Gunshot-related deaths and injuries temporarily show a dramatic decline when the National Rifle Association is holding its annual convention, according to a new analysis in the New England Journal of Medicine.

Vaping may help pneumonia-causing bacteria invade airways

(Reuters Health) - People who smoke e-cigarettes might have an increased risk of developing pneumonia because the vapor could help bacteria stick to cells lining the airways, a small experiment suggests.

Mylan teams up with Revance on biosimilar for Botox

NEW YORK (Reuters) - Mylan NV on Wednesday struck a licensing agreement to help bring Revance Therapeutics Inc's biosimilar of Allergan Plc's blockbuster Botox wrinkle treatment to the market.

FDA approves Sorrento's non-opioid painkiller patch, shares jump

(Reuters) - Sorrento Therapeutics Inc said on Wednesday the U.S. Food and Drug Administration has approved ZTlido, its non-opioid painkiller patch for nerve pain related to shingles, which it plans to launch later this year.

Real-time glucose monitor helps people with risky diabetes problem

(Reuters Health) - Continuous glucose monitoring devices may reduce episodes of dangerously-low blood sugar in adults with type 1 diabetes who suffer from so-called hypoglycemic unawareness, researchers say.

Doctor admits disclosing patient info to drugmaker Aegerion

BOSTON (Reuters) - A Georgia pediatric cardiologist pleaded guilty on Wednesday to wrongfully disclosing information about his young patients to an Aegerion Pharmaceuticals Inc sales representative seeking to identify potential new users of an expensive cholesterol drug.

FDA approves Sorrento's patch for after-shingles nerve pain

(Reuters) - Sorrento Therapeutics Inc is planning to launch later this year its stick-on patch to relieve nerve pain due to shingles, ZTlido, which received the U.S. Food And Drug Administration approval on Wednesday.

FDA approves Sorrento's painkiller patch

(Reuters) - The U.S. Food And Drug Administration on Wednesday approved Sorrento Therapeutics Inc's ZTlido, a stick-on patch to treat nerve pain due to shingles.

Another reason to worry about overcrowded emergency rooms

(Reuters Health) - Patients are more likely to be misdiagnosed or experience treatment delays when emergency rooms are so crowded that they receive care in a hallway, a survey of physicians suggests.

Coca-cola defeats U.S. lawsuit over Diet Coke ads

(Reuters) - A federal judge has dismissed a lawsuit claiming that Coca-Cola Co's advertising for Diet Coke misleads people into thinking that consuming the soft drink assists in weight loss, and that it actually causes weight gain.

Netherlands confirms highly pathogenic H5N6 bird flu outbreak

PARIS (Reuters) - The Netherlands confirmed an outbreak of highly pathogenic H5N6 bird flu at a farm in the northern part of the country, the World Organisation for Animal Health (OIE) said on Wednesday, citing a report from the Dutch ministry of Economic Affairs.

Yes, working hard in high school can pay off later

(Reuters Health) - High school students who are responsible and have solid reading and writing skills may be more likely to succeed in college and go on to snag a high-paying, prestigious job than their classmates who slack off, a new study confirms.

Europe follows FDA with plans to help early Alzheimer's drugs

LONDON (Reuters) - European regulators are following in the footsteps of the U.S. Food and Drug Administration with plans to help pharmaceutical companies win approval for novel Alzheimer's drugs that treat the earliest stages of the memory-robbing disease.